Floyd Taub
18Patents
7h-index
13Co-inventors
63Inventor score
Filing activity: Nov 23, 1984 → Mar 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4820630A | Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels | Emerging Cross-Sectional Technologies | 109 | Expired |
| US5068909A | Method and apparatus for generating quantifiable video displays | Physics | 61 | Expired |
| US5116734A | Highly sensitive method for detecting peroxidase | Physics | 35 | Expired |
| US6762174B1 | Low molecular weight compounds administered together with anti-cancer agents to prevent or treat cancer and pharmaceutical compositions thereof | Human Necessities | 27 | Expired |
| US6326136A | Macromolecular conjugate made using unsaturated aldehydes | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6166086A | Small molecules that increase the conversion of food to body weight gain | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6451853B1 | Small molecules that elicit a polarized Th1 response and for modulation of cellular immunity | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4873187A | Bifunctional DNA-protein conjugating agent | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6007819A | Methods of inducing immunity using low molecular weight immune stimulants | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6414114B2 | Disulfides and thiol compounds | Emerging Cross-Sectional Technologies | 5 | Expired |
| US10274491B2 | Biomarker signatures for lyme disease and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10725039B2 | Biomarker signatures for Lyme disease and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11672771B2 | Beta-alethine, immune modulators, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7071232B1 | Small molecules that increase the conversion of food to body weight gain | Human Necessities | 0 | Expired |
| US8815948B2 | High volume and alternative methods of delivering homeopathic remedies | Human Necessities | 0 | Active |
| US6498150B2 | Low molecular weight cell, bone marrow and immune stimulants | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9655870B2 | Homeopathic drug composition and methods of use thereof | Human Necessities | 0 | Active |
| US10725038B2 | Biomarker signatures for lyme disease differentiation and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.